Conference item icon

Conference item

Feno and blood eosinophils as biomarkers in predicting asthma exacerbations

Abstract:

With advances in new therapies that target airway inflammation, there is an urgent need for accurate and easy-to-use biomarkers to predict asthma exacerbations and likely patient responses to treatment. Blood and sputum eosinophilia are used to predict the response of patients with asthma to steroid therapy. Similarly, fractional exhaled nitric oxide (FeNO) concentrations has been shown to predict response to antiinflammatory therapy. Efforts have been made to correlate FeNO and blood eosino...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1136/thoraxjnl-2017-210983.340

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Target Discovery Institute
Oxford college:
St Edmund Hall
Role:
Author
ORCID:
0000-0002-4288-5973
Expand authors...
Publisher:
BMJ Publishing Group Publisher's website
Journal:
British Thoracic Society Winter Meeting 2017 Journal website
Host title:
British Thoracic Society Winter Meeting 2017
Publication date:
2017-11-15
DOI:
Source identifiers:
855780
Pubs id:
pubs:855780
UUID:
uuid:5899980a-dfdc-4c43-9ce2-fd3c8dcc7f8a
Local pid:
pubs:855780
Deposit date:
2018-08-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP